April 29, 2022 1:31 pm
Published by excellosadmin
Next-level characterization of donor immune cells can be used as a foundation for promoting high patient response rates. Last week... View Article
April 22, 2022 1:40 am
Published by excellosadmin
Donors play an important role in how well patients respond to immunotherapy, making donor characterization a critical success factor. Chimeric... View Article
March 22, 2022 2:04 pm
Published by excellosadmin
Scientists at the H. Lee Moffitt Cancer Center in Florida are investigating the potential for using tumor infiltrating lymphocytes in... View Article
March 10, 2022 11:14 pm
Published by excellosadmin
Scientists at GSK in Waltham, Massachusetts, are using Excellos-sourced T cell starting material for their preclinical evaluation of an anti-PD1... View Article
February 7, 2022 6:59 pm
Published by excellosadmin
T cell immunotherapy is a promising and relatively new field of medicine focused on tailoring a person’s own immune cells... View Article